284 related articles for article (PubMed ID: 22277881)
1. Tetrabromobisphenol-A disrupts thyroid hormone receptor alpha function in vitro: use of fluorescence polarization to assay corepressor and coactivator peptide binding.
Lévy-Bimbot M; Major G; Courilleau D; Blondeau JP; Lévi Y
Chemosphere; 2012 May; 87(7):782-8. PubMed ID: 22277881
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
3. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
[TBL] [Abstract][Full Text] [Related]
4. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
[TBL] [Abstract][Full Text] [Related]
5. Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: Xenopus as a model for endocrine perturbation studies.
Fini JB; Riu A; Debrauwer L; Hillenweck A; Le Mével S; Chevolleau S; Boulahtouf A; Palmier K; Balaguer P; Cravedi JP; Demeneix BA; Zalko D
Toxicol Sci; 2012 Feb; 125(2):359-67. PubMed ID: 22086976
[TBL] [Abstract][Full Text] [Related]
6. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
[TBL] [Abstract][Full Text] [Related]
7. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
[TBL] [Abstract][Full Text] [Related]
8. A new bioluminescent cellular assay to measure the transcriptional effects of chemicals that modulate the alpha-1 thyroid hormone receptor.
Jugan ML; Lévy-Bimbot M; Pomérance M; Tamisier-Karolak S; Blondeau JP; Lévi Y
Toxicol In Vitro; 2007 Sep; 21(6):1197-205. PubMed ID: 17532181
[TBL] [Abstract][Full Text] [Related]
9. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
[TBL] [Abstract][Full Text] [Related]
10. Ligand-dependent corepressor acts as a novel corepressor of thyroid hormone receptor and represses hepatic lipogenesis in mice.
Song Y; Shan S; Zhang Y; Liu W; Ding W; Ren W; Xia H; Li X; Zhang Q; Zhao L; Li X; Yan J; Ying H
J Hepatol; 2012 Jan; 56(1):248-54. PubMed ID: 21827732
[TBL] [Abstract][Full Text] [Related]
11. Expression of the rat alpha 1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformation change as a method for its purification to homogeneity.
Apriletti JW; Baxter JD; Lau KH; West BL
Protein Expr Purif; 1995 Jun; 6(3):363-70. PubMed ID: 7663174
[TBL] [Abstract][Full Text] [Related]
12. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain.
Tian H; Mahajan MA; Wong CT; Habeos I; Samuels HH
Mol Endocrinol; 2006 Sep; 20(9):2036-51. PubMed ID: 16645037
[TBL] [Abstract][Full Text] [Related]
13. Ioxynil and tetrabromobisphenol A suppress thyroid-hormone-induced activation of transcriptional elongation mediated by histone modifications and RNA polymerase II phosphorylation.
Otsuka S; Ishihara A; Yamauchi K
Toxicol Sci; 2014 Apr; 138(2):290-9. PubMed ID: 24449421
[TBL] [Abstract][Full Text] [Related]
14. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.
Jeyakumar M; Webb P; Baxter JD; Scanlan TS; Katzenellenbogen JA
Biochemistry; 2008 Jul; 47(28):7465-76. PubMed ID: 18558711
[TBL] [Abstract][Full Text] [Related]
15. A method for efficient production of recombinant thyroid hormone receptors reveals that receptor homodimer-DNA binding is enhanced by the coactivator TIF2.
Diallo EM; Thompson DL; Koenig RJ
Protein Expr Purif; 2005 Apr; 40(2):292-8. PubMed ID: 15766871
[TBL] [Abstract][Full Text] [Related]
16. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
17. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
Lin KH; Wu YH; Chen SL
Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
[TBL] [Abstract][Full Text] [Related]
18. Establishment of transactivation assay systems using fish, amphibian, reptilian and human thyroid hormone receptors.
Oka T; Mitsui-Watanabe N; Tatarazako N; Onishi Y; Katsu Y; Miyagawa S; Ogino Y; Yatsu R; Kohno S; Takase M; Kawashima Y; Ohta Y; Aoki Y; Guillette LJ; Iguchi T
J Appl Toxicol; 2013 Sep; 33(9):991-1000. PubMed ID: 23112079
[TBL] [Abstract][Full Text] [Related]
19. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
[TBL] [Abstract][Full Text] [Related]
20. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
